Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned persons hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.0013 per share of Progenics Pharmaceuticals, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof each of the undersigned, being duly authorized, hereby execute this Agreement on the date set forth below.
Date: April 5, 2019
| VELAN CAPITAL, L.P. | ||
| By: Altiva Management Inc., its general partner | ||
| By: | /s/ Stephanie P. Cooper | |
| Name: Stephanie P. Cooper | ||
| Title: President and Secretary | ||
| ALTIVA MANAGEMENT INC. | ||
| By: | /s/ Stephanie P. Cooper | |
| Name: Stephanie P. Cooper | ||
| Title: President and Secretary | ||
| BALAJI VENKATARAMAN | ||
/s/ Balaji Venkataraman | ||
| VIRINDER NOHRIA | ||
/s/ Virinder Nohria | ||
| LTE PARTNERS, LLC | ||
| By: LTE Management, LLC, its Manager | ||
| By: | /s/ Ryan Melkonian | |
| Name: Ryan Melkonian | ||
| Title: Member and Manager | ||
| LTE MANAGEMENT, LLC | ||
| By: | /s/ Ryan Melkonian | |
| Name: Ryan Melkonian | ||
| Title: Member and Manager | ||
| MELKONIAN CAPITAL MANAGEMENT, LLC | ||
| By: | /s/ Ryan Melkonian | |
| Name: Ryan Melkonian | ||
| Title: Managing Member | ||
| RYAN MELKONIAN | ||
/s/ Ryan Melkonian | ||
